TIMP-1 resistant matrix metalloproteinase-9 is the predominant serum active isoform associated with MRI activity in patients with multiple sclerosis

Sera from Remitting and Secondary Progressive Multiple Sclerosis Patients Disrupt the Blood-Brain Barrier

(2014) Fumitaka Shimizu et al.   PLoS One

Heterogeneity of serum gelatinases MMP-2 and MMP-9 isoforms and charge variants

(2013) Rocco Rossano et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Pathophysiology of the brain extracellular matrix: a new target for remyelination

(2013) Lorraine W. Lau et al.   NATURE REVIEWS NEUROSCIENCE

Serum Levels of Matrix Metalloproteinases: Implications in Clinical Neurology

(2012) Fredrik Romi et al.   EUROPEAN NEUROLOGY

Matrix metalloproteinase-9 activity detected in body fluids is the result of two different enzyme forms

(2012) T. Bellini et al.   JOURNAL OF BIOCHEMISTRY

Alterations in serum MMP-8, MMP-9, IL-12p40 and IL-23 in multiple sclerosis patients treated with interferon-β1b

(2010) JS Alexander et al.   Multiple Sclerosis Journal

Matrix metalloproteinases and their multiple roles in neurodegenerative diseases

(2009) Gary A Rosenberg   LANCET NEUROLOGY

Matrix metalloproteinase-9 and matrix metalloproteinase-2 as biomarkers of various courses in multiple sclerosis

(2009) Y Benešová et al.   Multiple Sclerosis Journal

Localizing central nervous system immune surveillance: Meningeal antigen-presenting cells activate T cells during experimental autoimmune encephalomyelitis

(2008) Pia Kivisäkk et al.   ANNALS OF NEUROLOGY

Matrix metalloproteinases as modulators of inflammation

(2007) A MANICONE et al.   SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY